End-stage renal disease was 3.4 times more likely to develop among patients with immunoglobulin A nephropathy compared with those who had minimal change disease, study finds.<div><a href="https://www.renalandurologynews.com/end-stage-renal-disease-rate-varies-fsgs-igan-ln-mn-mcd/article/742564/" target="_blank">Original link</a></div>